Matches in Wikidata for { <http://www.wikidata.org/entity/Q61939181> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q61939181 description "assaig clínic" @default.
- Q61939181 description "clinical trial" @default.
- Q61939181 description "clinical trial" @default.
- Q61939181 description "clinical trial" @default.
- Q61939181 description "clinical trial" @default.
- Q61939181 description "ensaio clínico" @default.
- Q61939181 description "ensayo clínico" @default.
- Q61939181 description "ensayu clínicu" @default.
- Q61939181 description "essai clinique" @default.
- Q61939181 description "klinisch onderzoek" @default.
- Q61939181 description "клінічне випробування" @default.
- Q61939181 description "临床试验" @default.
- Q61939181 name "Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients." @default.
- Q61939181 type Item @default.
- Q61939181 label "Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients." @default.
- Q61939181 prefLabel "Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients." @default.
- Q61939181 P1050 Q61939181-BF91578A-CD69-4664-A7A0-0E59E9F6609F @default.
- Q61939181 P1132 Q61939181-EAB602F9-BABA-4ED6-805C-01F2855F2753 @default.
- Q61939181 P1476 Q61939181-4E96B3D2-2F66-4AE4-9DAC-2C0DCD53F849 @default.
- Q61939181 P17 Q61939181-0149FEE5-CAA5-4BF6-9E86-8EC4BAE91D6A @default.
- Q61939181 P1813 Q61939181-63D27911-D9D8-4F4D-BD57-93ED635B7B9B @default.
- Q61939181 P2899 Q61939181-79E3D109-7D6F-4FC6-9A55-C2714D1C30C9 @default.
- Q61939181 P3098 Q61939181-C1C5BB94-705F-4A7F-8887-854CC956ADAA @default.
- Q61939181 P31 Q61939181-5F419213-DA49-458F-88DA-0363F7085E52 @default.
- Q61939181 P4844 Q61939181-6779660E-3423-4A24-BA81-45B9073E41B5 @default.
- Q61939181 P4844 Q61939181-7A841FB7-3D95-40D5-BC20-3BFA6A25E968 @default.
- Q61939181 P4844 Q61939181-E8CA3045-0CB1-47FB-A733-9D8D562A4EC3 @default.
- Q61939181 P580 Q61939181-5229304B-FD4A-4DF8-9FDB-CDA49C7986B8 @default.
- Q61939181 P582 Q61939181-17ABFA10-8931-4021-9DAD-59ECCACDB9AA @default.
- Q61939181 P6099 Q61939181-6B8F4179-5A28-40E0-9043-A22C90101612 @default.
- Q61939181 P6153 Q61939181-1BE3E756-934A-48A0-9A6B-4D63B78A5C95 @default.
- Q61939181 P6153 Q61939181-4B773C7E-E488-4FB7-B6BB-99EAABDC47C8 @default.
- Q61939181 P6153 Q61939181-FA7A1576-9E1C-46D7-9DE1-CB98AE7AE7B7 @default.
- Q61939181 P8005 Q61939181-CBAC5B6E-4CD2-4DDB-AC29-0239A985AAB3 @default.
- Q61939181 P8363 Q61939181-D7E651BD-840A-4A15-8A89-8853EED58B23 @default.
- Q61939181 P1050 Q356033 @default.
- Q61939181 P1132 "+69" @default.
- Q61939181 P1476 "A Non Randomized Phase II Trial to Assess Efficacy and Safety of Bevacizumab, Capecitabine and Oxaliplatin as First Line Treatment for Elderly Patients With Metastatic Colorectal Adenocarcinoma, Suitable for Polychemotherapy Treatment" @default.
- Q61939181 P17 Q29 @default.
- Q61939181 P1813 "BECOX" @default.
- Q61939181 P2899 "+70" @default.
- Q61939181 P3098 "NCT01067053" @default.
- Q61939181 P31 Q30612 @default.
- Q61939181 P4844 Q413299 @default.
- Q61939181 P4844 Q420207 @default.
- Q61939181 P4844 Q422327 @default.
- Q61939181 P580 "2009-11-01T00:00:00Z" @default.
- Q61939181 P582 "2010-11-01T00:00:00Z" @default.
- Q61939181 P6099 Q42824440 @default.
- Q61939181 P6153 Q219615 @default.
- Q61939181 P6153 Q3297837 @default.
- Q61939181 P6153 Q50562360 @default.
- Q61939181 P8005 Q76651279 @default.
- Q61939181 P8363 Q78089383 @default.